Prognostic Significance of Serum Total Cholesterol and Triglyceride Levels in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

Prognostic Significance of Serum Total Cholesterol and Triglyceride Levels in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

Lower cholesterol levels are associated with worse outcomes in patients with chronic heart failure (HF) and have been shown to predict in-hospital mortality. The relation between lipid profile and postdischarge outcomes in patients hospitalized for worsening HF is less clear. In this post hoc analys...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2013-02, Vol.111 (4), p.574-581
Hauptverfasser: Greene, Stephen J., MD, Vaduganathan, Muthiah, MD, MPH, Lupi, Laura, MD, Ambrosy, Andrew P., MD, Mentz, Robert J., MD, Konstam, Marvin A., MD, Nodari, Savina, MD, Subacius, Haris P., MA, Fonarow, Gregg C., MD, Bonow, Robert O., MD, Gheorghiade, Mihai, MD
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Body mass index
Cardiovascular
Cholesterol
Cholesterol - blood
Confidence intervals
Double-Blind Method
Female
Follow-Up Studies
Fractions
Heart Failure - blood
Heart Failure - mortality
Heart Failure - physiopathology
Hospital Mortality - trends
Hospitalization
Humans
Hypotheses
Inpatients
Kaplan-Meier Estimate
Male
Middle Aged
Mortality
Pharmaceuticals
Prognosis
Prospective Studies
Statins
Stroke Volume - physiology
Studies
Triglycerides
Triglycerides - blood
United States - epidemiology
Variables
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Lower cholesterol levels are associated with worse outcomes in patients with chronic heart failure (HF) and have been shown to predict in-hospital mortality. The relation between lipid profile and postdischarge outcomes in patients hospitalized for worsening HF is less clear. In this post hoc analysis of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST), 3,957 patients hospitalized for worsening HF with ejection fractions ≤40% were examined. Baseline total cholesterol and triglyceride levels were measured
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2012.10.042